Brotman Baty Institute for Precision Medicine Launches in Seattle

Jeffrey and Susan Brotman and Pam and Dan Baty have made a $50 million gift to create the Brotman Baty Institute for Precision Medicine... Read More
December 7, 2017

Government and life sciences sector agree transformative sector deal

A transformative Sector Deal between the UK life sciences sector and the government has today (Wednesday 6 December) been announced. This draws substantial investment... Read More
December 7, 2017

Blueprint Genetics CEO – clinical grade genetic testing becoming increasingly available

Blueprint Genetics CEO Tommi Lehtonen believes advances in clinical genetic testing will soon begin to feed into the genetic screening of healthy individuals. Clinical... Read More
December 7, 2017

XIFIN Announces Next-Generation Revenue Cycle Management with RPM 9 to Help Laboratories Improve Revenue, Patient Engagement and Reporting During Unprecedented Market Disruption

XIFIN, Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, and a Frost & Sullivan’s 2017 North American Revenue Cycle Management... Read More
December 7, 2017

South Africa’s CPGR to partner with The Sunflower Fund to stimulate medical innovation in Africa through access to high-resolution HLA testing and data aggregation

The Centre for Proteomic and Genomic Research (CPGR) today announced that it has entered into a partnership with The Sunflower Fund (TSF) to make... Read More
December 7, 2017

Canon BioMedical products now available in Austria, Germany, and Switzerland

Canon BioMedical is pleased to announce our latest geographic expansion into the German-speaking countries of Austria, Germany, and Switzerland. We are working with a... Read More
November 30, 2017

Philips teams with 3D printing industry leaders 3D Systems and Stratasys

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced agreements with 3D Systems and Stratasys, two global leaders in the... Read More
November 10, 2017

Definiens broadens Immuno-Oncology Service Offering

With the start of the 32nd Annual Meeting (November 8th-12th) of the Society for Immunotherapy of Cancer (SITC) in National Harbor, MD, Definiens, the... Read More
November 9, 2017

SeraCare Announces Industry’s First Comprehensive NGS Reference Material for Hematologic Malignancies

SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, is expanding what is already the most... Read More
November 8, 2017

Patrick Vallance, President, R&D, GSK to become UK Government’s Chief Scientific Adviser

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Dr Patrick Vallance, President, R&D, has informed the Board of his intention to leave the company to... Read More
November 8, 2017

University Hospital Bonn Announces New Technology To Advance Ability to Diagnose Rare Genetic Diseases in Children

The Institute for Genome Statistics and Bioinformatics, IGSB, and the Institute of Human Genetics, IHG, Bonn, have announced a new initiative to further precision... Read More
November 8, 2017

Sema4 Appoints Fertility Expert Alan Copperman, MD, as Chief Medical Officer

Sema4, a health information company providing advanced genomic testing, recently announced the appointment of Alan B. Copperman, MD, as Chief Medical Officer. Dr. Copperman... Read More
November 8, 2017

Personalis Wins New Contract to Sequence >34,000 Whole Human Genomes for the VA’s Million Veteran Program

Personalis, Inc., a provider of advanced genomic sequencing and analytics for immuno-oncology, today announced a new contract with the US Department of Veterans Affairs... Read More
November 8, 2017

Precision Medicine Meets Single-Cell DNA Analysis with Mission Bio

Mission Bio, Inc., a pioneer in single-cell DNA analysis, recently announced it has secured $10 million in Series A funding. Silicon Valley venture capital... Read More
November 2, 2017

Natera Chosen for Longitudinal Circulating Tumour DNA Study in Breast Cancer

Natera, Inc., (NASDAQ: NTRA), a global leader in cell-free DNA testing, has entered into a research collaboration with Imperial College London and the University... Read More
November 2, 2017

PAREXEL and Microsoft Form Cloud Technology Alliance Aimed at Accelerating the Pace of Drug Development

PAREXEL International Corp., a leading global biopharmaceutical services organization, and Microsoft Corp. announced a technology development alliance aimed at driving innovation across the life... Read More